Pseudoresistance in idiopathic/genetic generalized epilepsies - Definitions, risk factors, and outcome.

Abstract

OBJECTIVE:

The aim of the study was to determine risk factors associated with pseudoresistance in a large, representative cohort of patients with Idiopathic/Genetic Generalized Epilepsy (IGE) and the impact of pseudoresistance on socioeconomic parameters.

METHODS:

We performed a literature review on definitions of pseudoresistance in IGE. In an established cohort of patients with IGE from Funen, patients with current or previous pseudoresistant seizures were retrospectively identified based on a comprehensive evaluation of the patients' medical records and direct patient contact, if required. In addition, clinical characteristics, socioeconomic, and demographic data were assessed. Personal interviews were used to determine the brief version of Barratts (BIS-8) impulsivity score.

RESULTS:

The literature review provided the following definition of pseudoresistance: Seizures due to (I) lacking adherence to antiseizure medication (ASM), (II) incompliance to general rule of conduct, (III) psychogenic nonepileptic seizures (PNES), (IV) inadequate choice of ASM/dosage, and (V) incorrect classification of epilepsy. Applying criteria I-III to a cohort of patients with IGE (n = 499), 73 patients (14.6%) were currently pseudoresistant and 62 (12.4%) were previously pseudoresistant, but currently seizure free. Current pseudoresistance was associated with younger age, drug/alcohol abuse, lower rate of full-time employment, and higher BIS-8 scores. We found no associations of pseudoresistance with juvenile myoclonic epilepsy, psychiatric disease, specific seizure types, or number of seizure types. Patients with previously pseudoresistant seizures have tried more ASMs and were characterized by male preponderance, higher BIS-8, and higher rates of abuse. Surrogate markers for social outcome did not differ.

SIGNIFICANCE:

In IGE, pseudoresistance may be defined as PNES or insufficient adherence to medication/conduct and is associated with younger age, drug/alcohol abuse, and higher scores for impulsivity. If transient, its impact on socioeconomic status remains limited but may be associated with a risk of overtreatment with ASM.

• Authors: Joanna Gesche, Camilla Dyremose Cornwall, Line Delcomyn, Guido Rubboli, Christoph P Beier
• Journal: Epilepsy & behavior : E&B (Epilepsy Behav) Vol. 130 Pg. 108633 (05 2022) ISSN: 1525-5069 [Electronic] United States
• PMID: 35306367 (Publication Type: Journal Article, Review)
• Copyright: Copyright © 2022 The Author(s). Published by Elsevier Inc. All rights reserved.

Chemical References

• Immunoglobulin E

Topics

• Alcoholism (complications, epidemiology)
• Epilepsy, Generalized (drug therapy)
• Humans
• Immunoglobulin E (therapeutic use)
• Male
• Myoclonic Epilepsy, Juvenile
• Retrospective Studies
• Risk Factors
• Seizures